학술논문

Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: The first US phase 2 experience
Document Type
Article
Source
In: Pancreas. (Pancreas, May 2014, 43(4):518-525)
Subject
Language
English
ISSN
15364828
08853177